Výsledky vyhledávání - "Adilakshmi Gandham"

Abstract 1076: Targeting EGFR and PI3K pathways with KRASG12D inhibitor overcomes oncogenic dependence in pancreatic cancer

Autor: Prashant Kashinath Bhavar, Uday Kumar Surampudi, Adilakshmi Gandham, Partha Pratim Sarma

Publikováno v: Cancer Research. 83:1076-1076

In the U.S., pancreatic cancer is 9th most commonly diagnosed cancer (depending on gender), but the fourth leading cause of cancer death in men and women. FOLFIRINOX or gemcitabine plus nab-paclitaxel have been the standard of care for pancreatic can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f7c5adc93ef3308e459acd28291c73bd
https://doi.org/10.1158/1538-7445.am2023-1076

Zobrazit plný text záznamu

Abstract A037: PROTACs as emergent treatment modality of metastatic prostate cancer. [R

Autor: Prashant Kashinath Bhavar, Uday Kumar Surampudi, Partha Pratim Sarma, Satish Katike, Adilakshmi Gandham

Publikováno v: Cancer Research. 83:A037-A037

Prostate cancer is one of the most commonly diagnosed and fourth leading cause of cancer death in men, with low survival rates for metastatic cancers. Androgen receptor (AR) is one of the most altered Oncogenes in castration-resistant prostate cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a778bd1da6ea2a68b7c604d198d464d6
https://doi.org/10.1158/1538-7445.metastasis22-a037

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání